Clinical Trial Update: Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma

View source ↗

Summary

The clinical trial update reports on plasma glycosaminoglycans as diagnostic and prognostic biomarkers in patients who have undergone surgery for renal cell car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Chalmers University of Technology | Conditions: Renal Cell Carcinoma | Status: COMPLETED